Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 2, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

March 31, 2027

Conditions
Acute Ischemic Stroke
Interventions
DRUG

aspirin + clopidogrel

Enrolled patients with acute ischemic stroke will be randomly assigned to the clopidogrel plus aspirin group (300 mg loading dose of clopidogrel plus 160 mg aspirin on day 1; followed by clopidogrel 75 mg plus aspirin 81 mg daily from day 2-day 21, followed by aspirin 81 mg to be continued if no alternate treatment is indicated).

DRUG

Aspirin

Aspirin 81 mg once daily alone

Trial Locations (1)

T6G2B7

RECRUITING

University of Alberta Hospital, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT06638151 - Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime) | Biotech Hunter | Biotech Hunter